Cargando…
Multiomics analysis of tumor mutational burden across cancer types
Whether tumor mutational burden (TMB) is related to improved survival outcomes or the promotion of immunotherapy in various malignant tumors remains controversial, and we lack a comprehensive understanding of TMB across cancers. Based on the data obtained from The Cancer Genome Atlas (TCGA), we cond...
Autores principales: | Li, Lin, Bai, Long, Lin, Huan, Dong, Lin, Zhang, Rumeng, Cheng, Xiao, Liu, Zexian, Ouyang, Yi, Ding, Keshuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531462/ https://www.ncbi.nlm.nih.gov/pubmed/34745455 http://dx.doi.org/10.1016/j.csbj.2021.10.013 |
Ejemplares similares
-
NUDT21 Promotes Tumor Growth and Metastasis Through Modulating SGPP2 in Human Gastric Cancer
por: Zhu, Yong, et al.
Publicado: (2021) -
Corrigendum: NUDT21 promotes tumor growth and metastasis through modulating SGPP2 in human gastric cancer
por: Zhu, Yong, et al.
Publicado: (2023) -
A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo
por: Yan, Yan, et al.
Publicado: (2021) -
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
por: Alsaihati, Burair A., et al.
Publicado: (2021) -
Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer
por: Wang, Jun, et al.
Publicado: (2022)